| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.69B | 21.56B | 18.84B | 14.07B | 13.28B | 12.20B |
| Gross Profit | 8.42B | 8.15B | 7.44B | 5.77B | 5.26B | 4.75B |
| EBITDA | 3.37B | 3.07B | 2.63B | 1.78B | 1.49B | 1.40B |
| Net Income | 1.21B | 891.00M | 752.00M | 789.00M | 568.00M | 542.00M |
Balance Sheet | ||||||
| Total Assets | 27.94B | 27.87B | 27.33B | 15.38B | 14.17B | 13.54B |
| Cash, Cash Equivalents and Short-Term Investments | 5.21B | 4.54B | 4.29B | 2.94B | 3.08B | 2.87B |
| Total Debt | 12.04B | 12.32B | 12.23B | 2.82B | 2.37B | 2.15B |
| Total Liabilities | 19.15B | 19.26B | 19.14B | 7.50B | 6.67B | 4.52B |
| Stockholders Equity | 8.79B | 8.60B | 8.19B | 7.88B | 7.50B | 9.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.09B | 799.00M | -82.00M | 445.00M | 743.00M |
| Operating Cash Flow | 0.00 | 2.38B | 2.00B | 1.27B | 1.35B | 1.37B |
| Investing Cash Flow | 0.00 | -1.78B | -9.41B | -1.41B | -906.00M | -688.00M |
| Financing Cash Flow | 0.00 | -383.00M | 8.76B | -2.00M | -237.00M | -879.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥22.80B | 11.42 | ― | 3.09% | -3.47% | 14.42% | |
71 Outperform | ¥29.75B | 6.01 | ― | 2.70% | 68.12% | 110.52% | |
71 Outperform | ¥5.80B | 6.88 | ― | 3.48% | 3.40% | -25.64% | |
64 Neutral | ¥10.96B | 12.30 | ― | 4.11% | 14.46% | 18.49% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥2.07B | -53.42 | ― | 3.73% | -2.06% | -109.18% | |
44 Neutral | ¥2.03B | 3.99 | ― | ― | -15.38% | ― |